TORONTO, ONTARIO–(Marketwired – March 21, 2014) – PharmaCan Capital is pleased to announce that it recently closed its third round of private financing. “Investor response to PharmaCan Capital’s most recent financing was overwhelming” said PharmaCan CEO Paul Rosen. “We set out to raise $5,000,000 but due to a surge of demand in both Canada and the United States we raised $9,000,000. Over the last 12 months PharmaCan Capital has raised well over $10,000,000, uniquely positioning us to increase our strategic portfolio of investee companies and also to support the growth plans of those companies that we have already invested in” Rosen explained.
PharmaCan Capital, a Canadian based company, recently announced that their private financing in the third round has been on a surge.